Yatomi and colleagues provided the first precedent that ATRvD1 ameliorated BLM-induced pulmonary fibrosis in mice by decreasing collagen deposition and cellular accumulation and restoring the matrix metallopeptidase 9 (MMP-9) expression (21). The gene discussed is MMP9; the disease is pulmonary fibrosis.